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Cognitive processes, such as learning and memory, are essential for our adaptation to
environmental changes and consequently for survival. Numerous studies indicate that
hormones secreted during stressful situations, such as glucocorticoids (GCs), adrenaline
and noradrenaline, regulate memory functions, modulating aversive memory consolidation
and retrieval, in an interactive and complementary way. Thus, the facilitatory effects
of GCs on memory consolidation as well as their suppressive effects on retrieval are
substantially explained by this interaction. On the other hand, low levels of GCs are
also associated with negative effects on memory consolidation and retrieval and the
mechanisms involved are not well understood. The present study sought to investigate
the consequences of blocking the rise of GCs on fear memory retrieval in multiple tests,
assessing the participation of β-adrenergic signaling on this effect. Metyrapone (GCs
synthesis inhibitor; 75 mg/kg), administered 90 min before the first test of contextual or
tone fear conditioning (TFC), negatively affected animals’ performances, but this effect did
not persist on a subsequent test, when the conditioned response was again expressed.
This result suggested that the treatment impaired fear memory retrieval during the
first evaluation. The administration immediately after the first test did not affect the
animals’ performances in contextual fear conditioning (CFC), suggesting that the drug
did not interfere with processes triggered by memory reactivation. Moreover, metyrapone
effects were independent of β-adrenergic signaling, since concurrent administration with
propranolol (2 mg/kg), a β-adrenergic antagonist, did not modify the effects induced by
metyrapone alone. These results demonstrate that pre-test metyrapone administration
led to negative effects on fear memory retrieval and this action was independent of a
β-adrenergic signaling.
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INTRODUCTION
Emotional situations are better remembered than neutral ones
because they trigger the release of stress hormones, i.e.,
glucocorticoids (GCs), adrenaline and noradrenaline, which play
a critical modulating role in learning and memory (McGaugh
and Roozendaal, 2002; Sandi, 2011). Stressful conditions
activate the Hypothalamus-Pituitary-Adrenal (HPA) axis, the
main neuroendocrine mediator of the stress response (for
review, see Joëls et al., 2012), inducing the release of GCs
(cortisol in humans and corticosterone in rodents) by the
adrenal glands. GCs act in different brain areas, including the
hippocampus and amygdala, which are important for spatial and
emotional memory, respectively (Morris et al., 1982; LeDoux,
1992; McGaugh, 2000). GCs effects are mediated by two
receptors, the mineralocorticoid (MR) and glucocorticoid (GR)
receptors. The former has high affinity for natural GCs and
is predominantly occupied under basal conditions, whereas the
latter has low affinity for the natural ligand and is occupied
at the circadian peak and during stress (Reul and de Kloet,
1985; for review, see Joëls and de Kloet, 1994; Joëls and Baram,
2009). Pharmacological studies using agonists and antagonists
for these receptors demonstrate the importance of the MR/GR
balance on memory (Oitzl and de Kloet, 1992; Lupien et al.,
2002; Rimmele et al., 2010), testifying that both, in some way,
are relevant. GCs effects on memory are usually dependent
on their levels and the aversiveness of the task. For memory
acquisition GCs levels, but not task aversiveness, are essential
and an inverted U-shaped dose-response relationship is usually
observed (Conrad, 2005). However, for memory consolidation,
GCs impact depends on the task aversiveness. Chronic restraint
stress before Y-maze (a non-aversive task) impairs spatial memory
(Conrad et al., 1996). In turn, infusion of GR agonist into the
hippocampus after inhibitory avoidance training (an aversive
task) has a facilitatory effect (Roozendaal and McGaugh, 1997).
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Nevertheless, either high (de Quervain et al., 1998) or low
GCs concentrations (Lupien et al., 2002) impair memory
retrieval.
During stressful conditions, the adrenergic system is also
activated, both centrally and peripherally. Adrenaline is secreted
by the adrenal medulla and is the main peripheral product of
the sympathetic pathway influencing several central functions
such as memory retention, consolidation and information
processing (Gold and Van Buskirk, 1975; Dahlgren et al.,
1980; Berntson et al., 2003). During or following learning, the
increase in GCs or adrenaline concentration by drugs and other
treatments enhance memory in rodents and human subjects
(Gold and Van Buskirk, 1978; Williams and McGaugh, 1993;
Cahill and Alkire, 2003). As adrenaline does not cross the blood-
brain barrier, these central effects suggest the existence of a
peripheral-central pathway by which adrenaline can modulate
processes in the central nervous system (Izquierdo et al., 1959,
1960; Lawrence et al., 1995; Van Bockstaele et al., 1999).
After training, administration of noradrenaline or β-adrenergic
agonists into the basolateral complex of the amygdala (BLA)
improves memory retention on inhibitory avoidance and spatial
water maze tasks (Ferry and McGaugh, 1999; Hatfield and
McGaugh, 1999) whereas blocking noradrenaline effects with
β-adrenergic antagonist propranolol impairs retention (Hatfield
and McGaugh, 1999).
Studies reveal that GCs interact with the adrenergic system
modulating memory processes specially during stress conditions.
Roozendaal et al. studied extensively this interaction and
demonstrated that, by acting on the GR, GCs facilitate
noradrenergic activation in the nucleus of the solitary tract,
which in turn projects to the amygdala and modulates
memory consolidation (Roozendaal et al., 1999). Moreover,
Quirarte et al. (1997) also showed that the facilitatory
effect of the synthetic GC, dexamethasone, on memory
consolidation is dependent of β-adrenergic signaling into the
BLA, since the administration of β-adrenergic antagonists
blocks this dexamethasone effect. The interaction between
GCs and the adrenergic system is also extended to memory
retrieval. Systemic administration of propranolol (PROP),
a β-adrenoceptor antagonist, blocks corticosterone-induced
impairment of contextual memory retrieval (Roozendaal et al.,
2004a). Likewise, lesion into the BLA or infusion of a
β-adrenoceptor antagonist blocks the impairment on memory
retrieval caused by GR agonist infused into the hippocampus
(Roozendaal et al., 2003). Furthermore, impairment of retrieval in
the inhibitory avoidance or fear conditioning induced by restraint
stress or GCs administration depends on β2-adrenoceptors, which
activation decreases cAMP levels, an important intracellular
messenger required for the retrieval of hippocampus-dependent
memory (Schutsky et al., 2011).
The mechanisms by which high levels of GCs induce
deleterious effects on memory were extensively studied in the
past decades. Nevertheless, the impairment effect on memory
retrieval induced by low levels of GCs is still not well understood.
The present study sought to investigate this issue, by using an
inhibitor of GCs synthesis (metyrapone; MET) to prevent the
hormone elevation in response to re-exposure to the conditioned
stimulus. In addition, we also investigated whether the effects
induced by MET were dependent on β-adrenergic signaling
and if these effects could modify retrieval and subsequent




Male Wistar rats, aged 3 months, were obtained from the
Center for Development of Experimental Models (CEDEME)
of Universidade Federal de São Paulo and used in all
experiments. They were kept in groups of 5 rats per cage
in a temperature controlled room and maintained on a
standard 12:12 light/dark schedule (lights on at 7:00 h)
with free access to food and water. Animals were trained
and tested during the light phase (between 13:00 h and
16:00 h). All procedures were approved by the University Ethics
Research Committee, in accordance with international guidelines
for the care and use of animals in research (Protocol N◦
2073/11).
DRUGS AND ADMINISTRATION PROCEDURES
Metyrapone (2-metil-1, 2-di-3-piridil-1-propanona; 375 mg in
10 ml; Sigma®), an 11β-hydroxylase inhibitor, was dissolved in
vehicle solution containing 40% of propylene glycol and 60%
of 0.9% saline to reach the appropriate concentration. The final
dose of MET (75 mg/kg) was determined in a previous study
(unpublished data).
The β-adrenoceptor blocker Propranolol (Propranolol
hydrochloride; Sigma®) was prepared in the same vehicle as
MET. Initially, a dose-response curve was performed (10 mg in
10 ml for the 2 mg/kg dose; 25 mg in 10 ml for the 5 mg/kg
dose and 50 mg in 10 ml for the 10 mg/kg dose) and the dose
of propranolol chosen (2 mg/ kg) was administered on the
subsequent experiments.
The drugs and vehicle were administered i.p. in a volume of
2.0 ml/kg. The time of administration of each drug and vehicle is
shown on Table 1.
BEHAVIORAL PROTOCOLS
CONTEXTUAL FEAR CONDITIONING (CFC)
The training phase was performed in one session using a
conditioning chamber (30 × 21 × 30 cm) made by black acrylic
walls and metallic grids (0.4 diameter) spaced 1.2 cm each
and connected to a shock generator and control module (AVS
Projetos—São Paulo, Brazil). Animals were placed individually in
the apparatus and remained there for 2 min (habituation). After
habituation, rats received 5 foot shocks (0.8 mA; 1 s duration
and 30 s interval), being removed from the apparatus 1 min after
de last one. Freezing behavior, defined as complete immobility
of the animal with the absence of vibrissae and sniffing and
maintenance only of breathing movements (Fanselow and Bolles,
1979), was measured continuously and was used as measurement
of animal’s fear response. Four, 8 and 12 days after training
(Tests 1, 2 and 3, respectively), the animals were placed back in
the conditioning context and freezing was recorded for 5 min.
Data were expressed as percentage of time spent in freezing. The
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Table 1 | Treatment design used in the behavioral experiments.
Experiment Administration time Number of animals/Group
VEH MET PROP VEH + MET + VEH + MET +
VEH VEH PROP PROP












30 min before Test 1 9 PROP2 mg/kg (8)
PROP5 mg/kg (8)
PROP10 mg/kg (9)
Effects of combined acute
MET and PROP on retrieval
and subsequent memory
processing of CFC
MET (90 min) and
PROP (30 min)
before Test 1
10 8 9 9
Imediately after
Test 1




9 8 9 8
Effects of acute MET
and PROP on retrieval
and subsequent memory
processing of TFC




Effects of acute MET
on non-associative fear
expression
90 min before Test 10 10
MET effect on anxiety-like
behaviors and locomotor
activity
90 min before Test 5 5
The memory tasks used, the moment of administration of the drugs and the number of animals per group are shown.
context chamber was cleaned with alcohol 70% diluted in water
between animals.
TONE FEAR CONDITIONING (TFC)
The training phase was performed in one session using the
same chamber of contextual fear conditioning (CFC). Animals
were placed individually in the apparatus and remained there
for 2 min (habituation). After habituation, rats received 5 tone-
shock pairings (tone: 80 dB, 5 s duration; shock: 0.8 mA, 1 s
duration and 30 s interval; shock and tone terminated together),
being removed from the apparatus 1 min after the last pairing.
In testing sessions, a white cylindrical chamber (35 cm diameter,
60 cm height) with an acrylic lid was used. Rats were placed in the
apparatus and the tone was presented 5 times in the absence of
shocks, but replicating the training schedule. The tests sessions
were conducted in a different room from that where training
was carried out. Freezing was recorded for 5 min and was used
as measurement of animal’s fear response. Data were expressed
as percentage of time spent in freezing. The training and test
chambers were cleaned with alcohol 70% diluted in water between
animals.
NON-ASSOCIATIVE FEAR RESPONSE
To address a possible effect of MET treatment on fear expression,
the animals’ spontaneous fear response was evaluated. The
animals were individually placed in a cylindrical chamber
(35 cm diameter, 60 cm height), and remained there for 2 min
(habituation). Immediately after, rats were exposed to 3 tone
presentations (tone: 80 dB, 10 s duration, 50 s inter-tone interval).
To increase the aversiveness of the arena four 60-watt bulb lids
were turned on during the entire test. Freezing was recorded for
5 min and was used as a measurement of animal’s fear response.
Rats were treated with VEH or MET 90 min before the test. Data
were expressed as percentage of time spent in freezing. Between
animals, the chamber was cleaned with alcohol 70% diluted in
water.
OPEN FIELD TEST
MET effect on locomotor activity and anxiety-like behaviors
were tested in the Open Field apparatus. The apparatus
consisted in a 80 cm diameter cylindrical arena, divided in
three concentric circles, each subdivided in quadrants. The
animals were individually placed in the center of the arena
and allowed to freely explore it for 5 min. The time spent
in the center or peripheral areas, besides the total number
of squares crossed, were measured as indicators of anxiety-
like behavior and locomotor activity, respectively. Rats were
treated with VEH or MET 90 min before the test. Between
animals, the chamber was cleaned with alcohol 70% diluted in
water.
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FIGURE 1 | Acute metyrapone treatment reduced freezing behavior on
Test 1. (A) Metyrapone significantly reduced freezing on Test 1.
(B) Metyrapone reduced freezing on Test 1 and this effect did not persist on
subsequent tests. MET = metyrapone group (n = 9); VEH = vehicle group
(n = 10). *P < 0.05, compared to vehicle group; # P < 0.05, compared to
Test 1, for all groups; & P < 0.05, compared to Test 2, for all groups.
BLOOD SAMPLING AND CORTICOSTERONE ASSAY
Thirty min after Test 1, animals were decapitated and
their blood was collected in cooled vials containing EDTA.
These samples were centrifuged at 2300 rpm for 20 min
at 4◦C. Plasma was collected and frozen at −20◦C. CORT
levels were determined in duplicate by a double antibody
radioimmunoassay (RIA) method, using a commercial kit
(ICN Biomedicals, Costa Mesa, CA). The sensitivity of the
assay is 3.125 ng/ml and intra—and interassay variations
are, respectively, 10.3 and 7.1%. The method used was a
modification from the original developed by Thrivikraman et al.
(1997).
STATISTICS
Data are presented as mean ± SEM and were analyzed
with Statistica 7®. Normality and sphericity were verified.
Outliers (values above 2 S.D.) were discarded from the study.
Freezing time was analyzed by repeated measures ANOVA,
with Treatment as the between factor and Test (Test 1, Test 2,
Test 3) as the within factor. Student’s t test and One-way
ANOVA were also used to analyze the data from Test 1, tone
fear conditioning (TFC), Open Field and non-associative tests
results.
The relevance of differences was verified by Cohen’s d effect
size, using the effect size calculator available at the University of
Colorado website.1
Post hoc analysis was performed by Newman-Keuls, for
repeated measures analysis, or Duncan, for non-repeated
measures analysis. The significant level for statistical differences
was set at P ≤ 0.05.
1http://www.uccs.edu
RESULTS
EFFECTS OF ACUTE MET TREATMENT ON RETRIEVAL AND
SUBSEQUENT MEMORY PROCESSING OF CFC
MET administration before Test 1
To test the immediate effects of MET administration on
contextual memory retrieval, the animals were treated with
MET or VEH 90 min before the test. Pre-test MET-treated rats
displayed less freezing than VEH group (t17 = 2.50; P < 0.03)
(Figure 1A). This difference between the groups also showed a
large effect size (MET× VEH, d = 1.16).
When all three tests were analyzed, repeated measures ANOVA
showed a main effect of Test (F(2,34) = 44.43; P < 0.01) and a
Test× Treatment interaction (F(2,34) = 13.91; P < 0.01), in which
freezing behavior of MET-treated group was higher on Test 2 than
on Tests 1 and 3 and VEH-treated group displayed more freezing
on Test 1 than on subsequent tests (P < 0.01 for both groups and
tests) (Figure 1B).
MET administration after Test 1
To examine whether MET treatment interferes with post-
reactivation processes the animals were treated immediately after
Test 1. Repeated measures ANOVA revealed a significant effect of
Test (F(2,36) = 172.18; P < 0.01), in which freezing behavior on
Test 2 was lower than on Test 1 and was higher than on Test 3
(P < 0.01 for all comparisons) (Figure 2). There was no effect of
treatment or an interaction.
EFFECTS OF ACUTE PROPRANOLOL TREATMENT ON RETRIEVAL AND
SUBSEQUENT MEMORY PROCESSING OF CFC
Dose-response curve of propranolol administered before Test 1
To evaluate the effects of pre-test PROP treatment, the animals
were treated with different doses of PROP 30 min before being
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FIGURE 2 | Post-reactivation acute metyrapone treatment did not
modify fear memory expression. Metyrapone treatment immediately
after Test 1 did not modify fear memory expression. MET = metyrapone
group (n = 10); VEH = vehicle group (n = 10). # P < 0.05, compared to
Test 1, for all groups; & P < 0.05, compared to Test 2, for all groups.
tested. Repeated measures ANOVA showed a significant effect
of Test (F(2,60) = 65.68; P < 0.01) and an interaction Test ×
Treatment (F(6,60) = 4.25; P = 0.01). Post hoc analysis showed that
PROP 2 and PROP 5 groups displayed less freezing than VEH on
Test 1 (P = 0.04 and P = 0.01, respectively), with large effect sizes
(PROP 2× VEH, d = 0.99; PROP 5× VEH, d = 1.42) (Figure 3).
VEH and PROP 10 groups displayed more freezing on Test 1 than
on Test 2 (P< 0.01 for both groups), whereas on Test 3, all groups
exhibited a reduction of freezing behavior compared to Test 1
(P < 0.05 for all groups) (Figure 3).
EFFECTS OF ACUTE MET AND PROPRANOLOL COMBINATION ON
RETRIEVAL AND SUBSEQUENT MEMORY PROCESSING OF CFC
Drugs administration before Test 1
To test whether pre-test MET effects would depend on
β-adrenergic signaling, the animals were treated with MET and
PROP, respectively, 90 and 30 min before Test 1 in a double
i.p. injection design. Based on the dose-response experiment,
2 mg/kg of PROP was chosen. One-way ANOVA for Test 1
showed a significant difference (F(3,34) = 6.30; P < 0.01) and
Duncan test revealed that MET-treated groups exhibited lower
freezing than VEH + VEH group (P < 0.01) (Figure 4A).
Comparison of MET-treated with the other groups also revealed
large effect sizes (VEH + VEH × MET + VEH, d = 1.76;
VEH + VEH × MET + PROP, d = 1.26). Interestingly, PROP
treatment did not change MET-induced freezing behavior on
Test 1 (P = 0.72).
Analysis of the three test sessions using repeated measures
ANOVA revealed a main effect of Test (F(2,68) = 20.83; P < 0.01)
and a Test × Treatment interaction (F(6,68) = 11.84; P < 0.01),
in which MET-treated rats displayed higher freezing behavior on
FIGURE 3 | Acute propranolol treatment reduced freezing behavior on
Test 1. Acute propranolol treatment with 2 or 5 mg/kg before Test 1
reduced freezing behavior. PROP 2 = propranolol 2 mg/kg (n = 8); PROP
5 = propranolol 5 mg/kg (n = 8); PROP 10 = propranolol 10 mg/kg (n = 9);
VEH = vehicle group (n = 9). *P < 0.05, compared to vehicle group;
# P < 0.05, compared to Test 1, all groups.
Test 2 than on Test 1 (P < 0.01) and Test 3 (P < 0.02), whereas
VEH + VEH and VEH + PROP groups displayed less freezing
on Tests 2 and 3 than on Test 1 (P < 0.05 and 0.01, respectively)
(Figure 4B).
Corticosterone assay
Analysis of CORT levels 30 min after Test 1 did not detect
significant effects (P = 0.10). However the comparison between
MET and VEH groups revealed a large effect size (VEH + VEH
× MET + VEH, d = 1.2; VEH + VEH × MET + PROP, d = 2.07)
(Table 2).
Drugs administration after Test 1
Administration of the drugs immediately after Test 1 revealed that
freezing behavior on Test 3 was lower than on Tests 1 and 2 for all
groups (P < 0.01) (main effect of Test (F(2,60) = 63.49; P < 0.01)
(Figure 5).
Drugs administration without re-exposure to the context (Test 1)
To determine whether exposure to Test 1 could play a role
in the effects observed above, animals were not tested after
administration of the drugs and the results showed reduction of
freezing time from Test 2 to Test 3 in all groups (P < 0.01, for
all groups), with main effect of Test (F(1,30) = 290.86; P < 0.01)
and an interaction Test × Treatment (F(3,30) = 4.15; P < 0.02),
in which MET + VEH group exhibited a trend on Test 2 to differ
from VEH + PROP group (P = 0.07) (Figure 6).
EFFECTS OF ACUTE MET AND PROPRANOLOL ON RETRIEVAL AND
SUBSEQUENT MEMORY PROCESSING OF TFC
The hippocampus-independent task was carried out to establish
whether pre-test MET or PROP effects would be restricted to
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FIGURE 4 | Acute propranolol treatment did not modify the effect
induced by acute metyrapone treatment on contextual fear
memory. (A) Metyrapone treatment significantly reduced freezing on
Test 1 and this effect is not modify by PROP treatment.
(B) Metyrapone treatment 90 min before Test 1 reduced freezing
behavior on Test 1 and this effect did not persist on subsequent tests.
VEH + VEH = vehicle group (n = 10); MET + VEH = metyrapone group
(n = 8); VEH + PROP = propranolol group (n = 9); MET + PROP
= metyrapone and propranolol group (n = 9). *P < 0.05, compared to
control group; # P < 0.05, compared to Test 1, for all groups on Test 2
and for VEH + VEH and VEH + PROP on Test 3; & P < 0.05,
compared to Test 2, for MET-treated groups.
Table 2 | Corticosterone plasma levels of animals submitted to
different treatments.
Group Corticosterone plasma levels (ng/ml)
VEH + VEH 189.92 ± 23.40 (N = 4)
MET + VEH 142.28 ± 17.11 (N = 3)
VEH + PROP 205.27 ± 63.25 (N = 2)
MET + PROP 117.38 ± 7.90 (N = 4)
Blood samples were obtained 30 min after Test 1 and the values are presented
as mean ± SEM. The number of animals per group is shown in parenthesis.
contextual memory tasks or not. Analysis of Test 1 indicated
that all groups exhibited more freezing after than before tone
presentation (P < 0.01 for VEH + VEH and VEH + PROP
groups and P < 0.05 for MET + VEH group), with main
effects of Treatment (F(2,24) = 12.01; P < 0.01), Moment (pre
or post-tone) (F(1,24) = 135.03; P < 0.01) and an interaction
(F(2,24) = 10.57; P < 0.01). Compared to VEH + VEH group,
MET + VEH-treated rats displayed less freezing behavior after
tone presentation (P < 0.01) (Figure 7A). There was also a large
effect size when MET + VEH-treated group was compared with
VEH + VEH-treated group (d = 2.07).
Analysis of the three tests showed main effect of Test
(F(2,48) = 7.25; P < 0.01) and an interaction Test × Treatment
(F(4,48) = 18.18; P < 0.01). MET + VEH-treated group exhibited
less freezing behavior on Test 1 than on the other tests (P < 0.01
for both comparisons) while PROP + VEH-treated group
exhibited more freezing on Test 1 than on subsequent tests
(P < 0.02 for Test 2 and P < 0.03 for Test 3). Finally, VEH + VEH
FIGURE 5 | Acute metyrapone and propranolol treatments
immediately after contextual fear memory reactivation did not modify
fear memory expression. There were no differences between the groups
when the treatments were administered immediately after Test 1.
VEH + VEH = vehicle group (n = 8); MET + VEH = metyrapone group
(n = 7); VEH + PROP = propranolol group (n = 10); MET + PROP
= metyrapone and propranolol group (n = 9). &# P < 0.05, compared to
Test 1, for all groups; & P < 0.05, compared to Test 2, for all groups.
group exhibited less freezing behavior on Test 3 than on tests 1
and 2 (P < 0.03 for both comparisons) (Figure 7B).
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FIGURE 6 | Acute metyrapone and propranolol treatments without
first context exposure did not modify fear memory. There were no
differences between the groups when the treatments were administered
without Test 1 re-exposure. VEH + VEH = vehicle group (n = 9); MET + VEH
= metyrapone group (n = 8); VEH + PROP = propranolol group (n = 9);
MET + PROP = metyrapone and propranolol group (n = 8). & P < 0.05,
compared to Test 2, for all groups.
EFFECTS OF ACUTE MET ON NON-ASSOCIATIVE FEAR EXPRESSION
This experiment was conducted to investigate the effects of MET
treatment on the animals’ innate fear response by assessing the
drug effects on a non-associative task. There was a main effect
of time, in which animals displayed more freezing after tones
(t19 = 6.82; P < 0.001) without differences between the groups
on freezing behavior before (t18 = 1.9; P > 0.05) or after tone
presentations (t18 = 0.69; P = 0.5) (Figure 8).
MET EFFECT ON ANXIETY-LIKE BEHAVIORS AND LOCOMOTOR
ACTIVITY
The effects of MET treatment on anxiety-like behaviors and
locomotor activity were evaluated in the Open Field test. MET-
treated rats did not differ from VEH-treated ones regarding
the total number of quadrants crossed (t13 = −0.29; P = 0.7)
(Figure 9A). Furthermore, the time spent in the center or
peripheral areas of the apparatus were similar between the groups
(Time in the center (t8 = 0.69; P = 0.5); Time in the periphery
(t8 = 0.04; P = 0.9)) (Figures 9B,C).
DISCUSSION
The present study aimed to investigate how blockade of GCs
rising in response to an aversive stimulus impacts retrieval and
subsequent fear memory processing and whether these effects
require adrenergic signaling. MET, a GCs synthesis inhibitor,
clearly reduced freezing behavior when administered before
the first re-exposure to the conditioned stimulus, suggesting
that retrieval of fear memory was impaired in CFC and
TFC tasks. The fact that similar results were obtained in
both hippocampus-dependent and independent tasks, suggest
that MET acts in pathways and/or brain structures common
to these tasks and known to present GCs receptors, such
as the amygdala (Reul and de Kloet, 1985; Phillips and
LeDoux, 1992; Joëls and de Kloet, 1994). The impairment
on retrieval induced by MET was restricted to the first test,
FIGURE 7 | Acute pre-test 1 metyrapone treatment had similar effects on
CFC and TFC. (A) Metyrapone treatment reduced freezing on test 1 after
tone exposure. (B) Metyrapone treatment reduced freezing behavior on test 1
but this effect did not persist in subsequent tests VEH + VEH = vehicle group
(n = 10); MET + VEH = metyrapone group (n = 8); VEH + PROP = propranolol
group (n = 9). *P < 0.05, compared to control group; § P < 0.05, comparing
pre and post-tone moment. # P < 0.05, compared to Test 1, for all groups;
& P < 0.05, compared to Test 2, only for MET + VEH and VEH + VEH groups.
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FIGURE 8 | Acute metyrapone treatment did not impair animal’s ability
to express fear. Metyrapone treatment did not reduce freezing after three
unknown and potentially threatening tone presentations. VEH = vehicle
group (n = 10); MET = metyrapone group (n = 10). § P < 0.05, comparing
pre and post-tone.
whereas in the subsequent evaluation (Test 2), in the absence
of MET, fear conditioned memory was expressed. In the
last test (Test 3), all groups displayed low levels of freezing
behavior, indicating that extinction—a process by which the
conditioned stimuli no longer predicts the occurrence of the
unconditioned stimuli—took place (for review, see Myers and
Davis, 2002).
Retrieval impairment in classical conditioning, an example
of implicit memory in rodents, and in the radial arm water
maze (Salehi et al., 2010), an example of explicit memory, is in
accordance with studies in humans showing a dose-dependent
effect of GCs on explicit memory tasks (Lupien et al., 2002;
Rimmele et al., 2010). Moreover, Marin et al. (2011) also observed
that a double, but not a single dose, of MET before retrieval of
emotional information impairs this process and this effect persists
for 4 days, suggesting a reduction of the strength of the memory
trace. Taking together these findings indicate an inverted U-shape
curve effect of GCs on retrieval, as proposed for other memory
processes. However, the restricted MET effect on Test 1 could be
interpreted as a consequence of increased release of corticotropin
releasing hormone (CRH), due to reduced GCs negative effect
on the HPA axis. This hypothesis is based on evidence showing
that CRH impairs hippocampal function and implicit memory
(Maras and Baram, 2012). Alternatively, this effect could be due
to a nonspecific influence of the drug on freezing expression or
on anxiety-like behavior. Regarding the former, MET did not
alter the animal’s fear response to an unknown and threatening
stimulus compared to VEH-treated rats, indicating that MET
impaired memory recall rather than interfered with the animal’s
ability to express fear. As for the latter, animals treated with MET
FIGURE 9 | Metyrapone treatment did not modify animal’s
anxiety-like behaviors and locomotor activity. (A) Metyrapone
treatment 90 min before the Open Field test did not interfere with
animal’s locomotor activity. (B) Time spent in the center of the arena.
(C) Time spent in the periphery of the arena. VEH = vehicle group
(n = 5); MET = metyrapone group (n = 5).
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90 min before an Open Field Test session did not display changes
in locomotor activity and time spent in the central or peripheral
areas of the apparatus, suggesting that MET did not interfere
with anxiety-like behaviors, as it is observed with anxiolytic drugs
(Treit and Fundytus, 1988).
Behavioral changes induced by MET on Test 2 of both
CMC and TFC could also point out to an interference of this
treatment on memory, since MET-treated animals displayed
more freezing behavior in Test 2 than in Test 1, indicating that
memory of the aversive event was preserved and MET-treated
groups were unable to access it on Test 1. The hypothesis of
retrieval blockade is strengthened by the similar freezing behavior
observed on Test 2 in pre-test MET groups and VEH + VEH
group, which was not re-exposed to Test 1 (50–55% of freezing
time). Moreover, the freezing behavior observed in pre-test MET
groups on Test 2 was not expected from animals undergoing
extinction process. If that had happened, then MET groups
should have displayed freezing behavior similar to VEH group
on Test 2. Taking together these comparisons and the non-
associative test result, there are strong evidences that pre-test
MET treatment had an effect on memory and did not directly
affect freezing expression on Test 1. Alternatively, regaining
the conditioned response on Test 2 could be interpreted as
the result of MET effects on subsequent memory processing,
that involves post-reactivation phenomena such as extinction
or reconsolidation, triggered by memory retrieval (Nader et al.,
2000; for review, see Myers and Davis, 2002). Reconsolidation
is a process that maintains or updates the original memory
after its destabilization induced by retrieval (Nader et al., 2000),
whereas extinction represents the acquisition of new information,
an inhibitory learning that reduces the frequency and amplitude
of the conditioned response (for review, see Myers and Davis,
2002). Thus, the results of Test 2 could indicate either an
impairment of extinction or an enhancement of reconsolidation.
Additional evidence of these effects was obtained with MET
administration immediately after Test 1 of the CFC, when no
differences between groups were observed in subsequent tests,
i.e., both groups displayed low levels of freezing, suggesting that
memory was not modified and extinction of the conditioned
response occurred. The absence of effect induced by MET on
post-test 1 condition suggests that the treatment did not interfere
with post-reactivation processes, as we previously speculated,
reinforcing the idea that MET actions could be restricted to
memory retrieval. We should however bear on mind that on
post-test 1 experiment perhaps the optimal inhibitory effect of
MET, i.e., 90 min after its administration, was not reached,
precluding this protocol as an adequate approach for evaluation of
a possible modulatory role of GCs on post-reactivation processes.
To separate and evaluate each process we should use longer
re-exposure duration for extinction analysis and a well-known
treatment that interferes with reconsolidation to compare its
effects with those of MET. There are studies suggesting a role
of GCs or stress on memory extinction and reconsolidation.
Barret and Gonzalez-Lima (2004) showed that MET influences
extinction of TFC, using an extinction training design and
treating animals 90 min before training. Blundell et al. (2011)
also demonstrated that corticosterone facilitates extinction while
MET prevents it. GR activation by a specific agonist or by
dexamethasone prior to extinction training facilitates this process
in a dose-dependent manner (Yang et al., 2006). For memory
reconsolidation, Maroun and Akirav (2008) showed that exposure
to a stressor (elevated platform) immediately after memory
reactivation impairs memory reconsolidation, being this effect
reversed by GR antagonist infusion into the BLA.
Pre-test administration of PROP also impaired memory
retrieval on Test 1 at 2 and 5 mg/kg, corroborating previous
studies showing deleterious effects of this drug on spatial memory
retrieval in rodents (Murchison et al., 2004). The importance
of the adrenergic signaling for retrieval in hippocampus-
dependent tasks is also demonstrated in a study with dopamine
β-hydroxylase gene knockout mice (Murchison et al., 2004).
Administration of β1-adrenergic antagonists such as betaxolol
also impairs retrieval, suggesting that β1-adrenergic receptors
are important for this memory process (Schutsky et al.,
2011). In the last test (Test 3) all groups treated with
PROP showed low freezing behavior, similar to VEH group,
indicating that extinction took place. Ouyang and Thomas (2005)
showed that PROP treatment before retrieval reduced freezing
behavior, but prevented extinction evaluated on a subsequent
test. The divergence between the present extinction data and
the aforementioned one could rely on the different PROP
isomers/doses and/or animal models used in each study. In our
study, PROP treatment did not reduce freezing behavior in the
first TFC test and this result is in disagreement with Rodriguez-
Romaguera et al. (2009) findings that showed reduced fear
expression, without impairment of fear extinction. This difference
could be explained by the dose of PROP and/or by the different
rat strain used in each study. Although Rodriguez-Romaguera
et al’s results suggest a modulation of β-adrenergic signaling on
fear expression, Murchison et al. (2004) provide another evidence
for the lack of adrenergic influence in this task by showing
that dopamine β-hydroxylase gene knockout mice exhibited no
difference in TFC as they did in CFC, suggesting a different role of
adrenergic signaling in each task. Speculatively, the lack of PROP
effect in TFC could be due to the administration of vehicle before
propranolol treatment, since in previous studies the drug was
administered alone or before any other manipulation, avoiding
interferences (Murchison et al., 2004; Ouyang and Thomas,
2005).
Finally, we conducted a set of experiments to test whether MET
effects on memory were dependent of adrenergic signaling, by
treating the rats with a combination of the drugs. Association of
the lowest effective PROP dose (even though in this experiment
this dose did not produce any effect) with MET did not change
the effects observed with MET alone, suggesting that MET-
induced retrieval impairment is independent of a β-adrenergic
signaling, contrary to what is proposed for high GCs levels
(Roozendaal et al., 2004a; Schutsky et al., 2011). This result
corroborates the hypothesis that the interaction between GCs
and the adrenergic system involves GR activation, as shown
by Roozendaal et al. (2004b). Since MET is known to prevent
stress-induced GCs elevation and a 90 min interval after
MET effectively inhibits corticosteroid synthesis (Roozendaal
et al., 1996; Cordero et al., 2002), activation of GR in our
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study was unlikely to have occurred. Our corticosterone assay
did not reveal the expected differences between MET-treated
groups and VEH group probably due to the small sample
size. Nevertheless, MET-treated animals exhibited large effect
sizes when compared to VEH group, suggesting the existence
of a relevant biological difference. Moreover, if there were any
interaction between the treatments the selected doses should be
sufficient to reveal this effect, since a study that investigated
the interaction between glutamatergic and cholinergic systems
on classical fear conditioning showed that sub-effective doses of
the drugs, which alone did not induce any effect, are sufficient
to reveal an interaction (Figueredo et al., 2008). On Test 2, all
groups treated with MET showed increased freezing behavior,
indicating again that these groups did not expressed fear memory
during Test 1, but did so, on Test 2. VEH and PROP-treated
animals, in turn, displayed a reduction in freezing in the second
evaluation compared to the first, suggesting that extinction
process began after the first re-exposure to the context for these
groups.
Taking these findings together we suggest that MET
treatment impaired context and tone fear memory retrieval
in a β-adrenergic signaling independent process. The fact that
MET administered immediately after the first context re-exposure
or 4 days after training without exposure to this test was unable
to induce behavioral changes strongly suggests that pre-test
administration acts only on memory retrieval and has no effect
on subsequent memory processing. This specific effect on
retrieval is reinforced by the absence of difference found on
the non-associative test and on anxiety-like behaviors. In the
post-test administration experiment, VEH + VEH group showed
a percentage of freezing not expected for a control group. Even so
the result from this experiment was not invalidated once freezing
behavior from VEH-treated group in all other experiments was
similar to MET and PROP-treated groups in this experiment
(approximately 55%), indicating that, indeed, there were no
differences between the groups.
In conclusion, our findings suggest that pre-test MET
administration impaired fear memory retrieval, in hippocampus-
dependent and independent tasks, and this action was
independent of a β-adrenergic signaling. In addition, our
results suggest that pre-test PROP treatment also negatively
impacts CFC but not TFC.
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